Journal article
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study
Authors
Keith PK; Cowan J; Kanani A; Kim H; Lacuesta G; Lee JK; Chen J; Park M; Gladiator A
Journal
Allergy, Asthma & Clinical Immunology, Vol. 19, No. 1,
Publisher
Springer Nature
DOI
10.1186/s13223-023-00805-3
ISSN
1710-1484